RxSight (RXST) Treasury Shares (2020 - 2025)

RxSight's Treasury Shares history runs 6 years deep, the most recent figure standing at $812227.0 for Q4 2025.

• Quarterly Treasury Shares rose 38.73% year-over-year to $812227.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $812227.0 (up 38.73% YoY) and the FY2025 annual result came in at $812227.0, up 38.73% from the prior year.
• Treasury Shares was $812227.0 for Q4 2025 at RxSight, up from $585458.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $14.4 million in Q1 2021 and bottomed at $492862.0 in Q4 2022.
• A 5-year average of $4.6 million and a median of $650357.0 in 2023 frame the typical range for Treasury Shares.
• Peak annual rise in Treasury Shares reached 279.64% in 2021, while the deepest fall reached 83.2% in 2021.
• RxSight's Treasury Shares stood at $640479.0 in 2021, then fell by 23.05% to $492862.0 in 2022, then surged by 31.96% to $650357.0 in 2023, then dropped by 9.98% to $585458.0 in 2024, then surged by 38.73% to $812227.0 in 2025.
• Business Quant data shows RXST's Treasury Shares at $812227.0 in Q4 2025, $585458.0 in Q4 2024, and $650357.0 in Q4 2023.